Therapeutic Targeting of the GIP Receptor—Revisiting the Controversies
Diabetes · 01.08.2025 · 74 (8) · 1320-1325
DOI: 10.2337/db25-0393 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, online erschienen am 16.06.2025. Verfasst von Jonathan E Campbell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Duke Molecular Physiology Institute, Durham, NC. Hauptthemen laut MEDLINE: Receptors, Gastrointestinal Hormone, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Current and emerging strategies to therapeutically target weight management include pairing agonism of the glucagon-like peptide 1 receptor (GLP-1R) with either agonism or antagonism of the glucose-dependent insulinotropic polypeptide receptor (GIPR). On the surface, these two approaches seem contradictory, yet they have produced similar effects for weight loss in clinical studies. Arguments that support the rationale for both approaches are made in these point-counterpoint articles, founded on preclinical studies, human genetics, and clinical outcomes. Here, we attempt to reconcile how two opposing approaches can produce similar effects on body weight by evaluating the leading hypotheses derived from the available evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Duke Molecular Physiology Institute, Durham, NC.
- Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Jonathan E Campbell, Daniel J Drucker
Förderung
- NIDDK NIH HHS
- CIHR
- Canadian Institutes of Health Research
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Campbell, J. E., & Drucker, D. J. (2025). Therapeutic Targeting of the GIP Receptor—Revisiting the Controversies. Diabetes, 74(8), 1320-1325. https://doi.org/10.2337/db25-0393
Vancouver
Campbell JE, Drucker DJ. Therapeutic Targeting of the GIP Receptor—Revisiting the Controversies. Diabetes. 2025;74(8):1320-1325. doi:10.2337/db25-0393
BibTeX
@article{Campbell2025,
author = {Campbell, Jonathan E and Drucker, Daniel J},
title = {Therapeutic Targeting of the GIP Receptor—Revisiting the Controversies},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {8},
pages = {1320--1325},
doi = {10.2337/db25-0393}
}
EUVIMED